Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome

This publication has 25 references indexed in Scilit:

• Wilms’ Tumor: Single Centre Retrospective Study from South India
  Indian Journal of Surgical Oncology, 2013
• Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India
  Pediatric Surgery International, 2013
• The prognostic significance of blastemal predominant histology in initially resected Wilms’ tumors: A report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan
  Journal of Pediatric Surgery, 2012
• Glypican-3: A new target for cancer immunotherapy
  European Journal of Cancer, 2011
• The cytomorphologic spectrum of Wilms tumour on fine needle aspiration: a single institutional experience of 110 cases
  Cytopathology, 2011
• Apoptotic protein expression in favorable-histology Wilms tumor correlates with tumor recurrence
  Pediatric Surgery International, 2010
• Management of Wilms′ tumor: NWTS vs SIOP
  Journal of Indian Association of Pediatric Surgeons, 2009
• Doxorubicin for favorable histology, Stage II–III Wilms tumor
  Cancer, 2004
• WILMS' TUMOR
  Urologic Clinics of North America, 2000
• Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome
  Nature Genetics, 1996